Navigation Links
The Lupus Foundation of America, Inc. Asks Supporters to Band Together for Lupus(SM)
Date:9/22/2009

The LFA asks people to join them and show their support by wearing a purple LFA wristband until there is an FDA-approved medication specifically for lupus

WASHINGTON, Sept. 22 /PRNewswire-USNewswire/ --It's been 50 years since the U.S. Food and Drug Administration (FDA) approved a medication to treat lupus -- when Dwight D. Eisenhower was President! To highlight the need for safer, more tolerable, and effective medications, the Lupus Foundation of America, Inc. (LFA) today launched its new campaign, Band Together for Lupus(SM), which encourages people to wear an LFA purple wristband until there is a medication approved specifically for lupus by the FDA. Current medications for lupus have unacceptable side effects that include bone loss and osteoporosis, infections, infertility, cancer, and more. The campaign also seeks to show support for those who are working to find new treatments and offer hope to the estimated 1.5 million Americans and 5 million people worldwide who have lupus.

"While we are encouraged that there are several promising treatments for lupus in the near-term pipeline there is still a lot of work to be done," said Sandra. C. Raymond, LFA President and CEO. "This is why we are asking all of our supporters to join us in 'banding together' for the millions of people who are affected by the disease."

The campaign Web site (www.lupus.org/bandtogether) allows people to purchase LFA wristbands, and complete a form pledging their support and commitment to wearing the wristband. The Web site also has more information on the campaign and how people can get involved and support the LFA.

About Lupus

Lupus is an acute and chronic autoimmune disease in which the immune system is unbalanced, causing inflammation and tissue damage to virtually any organ in the body. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure. Ninety percent of the people with lupus are women, and it is two to three times more common among African Americans, Hispanics/Latinos, Native Americans, and Asians. Lupus is unpredictable and potentially fatal, yet no satisfactory treatment or cure exists.

About the LFA

The Lupus Foundation of America, Inc. is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. The LFA and its national network of chapters and support groups operate programs of research, education, and advocacy. To learn more, visit www.lupus.org.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lupus Worse in Blacks, Hispanics Than in Whites, Study Finds
2. The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs
3. Flu Shot May Be Less Effective in Those With Lupus
4. Immune responses to flu vaccine are diminished in lupus patients
5. LFAGW to Offer First Living with Lupus Baltimore Workshop on August 15
6. Reminder - Human Genome Sciences to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus
7. LFAGW to Run Could I Have Lupus? Workshop on July 26; Mystics Game Follows
8. Basic Facts and Statistics About Lupus
9. The New York Times Website Patient Voices Series Features People Affected by Lupus
10. Lupus Foundation of America Accepting Letters of Intent for Research Grants on Adult Stem Cell Research and Health-Related Quality of Life in Pediatric Lupus
11. Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Providing for ... understand the estate planning process, or where to even begin. “Now more than ever ... you are to properly protect yourself and your family,” said attorney Lisa Edgar Dickman, ...
(Date:4/21/2017)... ... April 21, 2017 , ... Westside Dental Associates ... dental care since 1985. After thirty-two years, Dr. Latner has become one of the ... my numerous clients over the years with all their dental needs,” said Dr. Latner, ...
(Date:4/21/2017)... ... ... Each year, everyone is urged to give back to the earth on April ... a better future. However, supporting the environment should be an everyday practice. , ... to five times more polluted than outdoor air, reports the Environmental Protection Agency -- ...
(Date:4/21/2017)... Houston, Texas (PRWEB) , ... April 21, 2017 ... ... repeal…. sound familiar? These are five common elements between the Obamacare program ... feral hog control program which uses Warfarin poison to kill hogs. , ...
(Date:4/21/2017)... ... April 21, 2017 , ... Indiana ... significant bandwidth upgrade infrastructure service to Tele-Media Solutions. IFN is delivering Multi-Gigabit ... IFN’s consortium member-owners, Tele-Media Solution’s protect transport with 3GB Dual Access Internet access ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Eyevensys, a private biotechnology company developing its ... that enables the safe, local, sustained production of therapeutic ... of ophthalmic diseases, announces it has received approval from ... to advance its technology into clinical development. ... The EyeCET platform uses ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: